Sign In
Buy ETON
$27.61
+0.210 (+0.766%)
At Close: Jun 03, 2026
Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run?
11:00am, Wednesday, 16'th Aug 2023
Eton Pharmaceuticals, Inc. (ETON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
08:09am, Friday, 11'th Aug 2023
Eton Pharmaceuticals (NASDAQ: ETON ) stock is soaring following the release of its earnings report for the second quarter of 2023! The big new exciting investors in ETON stock is its earnings per sha
Eton Pharmaceuticals, Inc. (ETON) Q2 2023 Earnings Call Transcript
08:32pm, Thursday, 10'th Aug 2023
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - CEO James Gruber - CF
Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates
07:01pm, Thursday, 10'th Aug 2023
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to loss of $0.06 per share a yea
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
04:05pm, Tuesday, 01'st Aug 2023
DEER PARK, Ill., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare disease
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.21 per share a year ago.
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
04:05pm, Wednesday, 03'rd May 2023
DEER PARK, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates
07:05pm, Thursday, 16'th Mar 2023
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 300% and 6.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
04:05pm, Tuesday, 07'th Mar 2023
DEER PARK, Ill., March 07, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseas
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Strong Buy: Here's What You Should Know
01:33pm, Wednesday, 08'th Feb 2023
Eton Pharmaceuticals, Inc. (ETON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 25th
09:02am, Wednesday, 25'th Jan 2023
YEXT, CXM, ETON, OKTA, VZLA have been added to the Zacks Rank #1 (Strong Buy) List on January 25, 2023.
Best Momentum Stocks to Buy for January 23rd
11:17am, Monday, 23'rd Jan 2023
ETON, KMTUY and AU made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 23, 2023.
New Strong Buy Stocks for January 23rd
09:02am, Monday, 23'rd Jan 2023
GFI, AU, ETON, KMTUY and STLA have been added to the Zacks Rank #1 (Strong Buy) List on January 23, 2023.
Volume Breakout Report Update: Buy Eton Pharmaceuticals
10:41pm, Monday, 16'th Jan 2023
A number of VBR "green energy" picks have popped higher in January, pulling investment returns for the group of past picks strongly higher. A performance review of 46 previous selections since late Ju
ETON Up as FDA Accepts NDA for Dehydrated Alcohol Injection
12:02pm, Thursday, 12'th Jan 2023
Eton (ETON) gains as the its new drug application (NDA) for dehydrated alcohol injection for methanol poisoning is accepted for review by the FDA.
